SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-051471
Filing Date
2018-09-18
Accepted
2018-09-18 16:27:48
Documents
1
Period of Report
2018-09-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3871
  Complete submission text file 0001209191-18-051471.txt   5194
Mailing Address 200 GARRETT STREET CHARLOTTESVILLE VA 22902
Business Address 200 GARRETT STREET CHARLOTTESVILLE VA 22902 434-980-8100
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address
Palczuk Linda (Reporting) CIK: 0001717580 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38529 | Film No.: 181075996